SOLID BIOSCIENCES INC
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
Solid Biosciences Inc. is a life sciences company that is focused on developing transformative treatments to improve the lives of patients with neuromuscular and cardiac diseases. SGT-001 and SGT-003 are its gene transfer candidates. Its neuromuscular and cardiac programs, including SGT-003, a differentiated gene transfer candidate, for the treatment of Duchenne, AVB-202, a gene transfer candidate for the treatment of Friedreichs ataxia, and AVB-401 for BAG3 mediated dilated cardiomyopathy. Its SGT-003 are designed to address the underlying genetic cause of Duchenne by delivering a synthetic transgene that produces dystrophin-like protein that is only expressed in muscles of the body, including cardiac and respiratory muscles. In addition to gene transfer candidates, the Company has development programs focusing on platform technologies, including novel capsid libraries and dual gene expression, a technology that allows to package multiple transgenes into one vector.
Buy US stocks in Australia starting with SLDB. Open an account and start investing today!
Ready to start your investing journey with Stake?Open an account
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake Wall St
- Deposit directly into your Stake wallet and you're ready to invest in SLDB
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SLDB
Buy SLDB from US$3 brokerage
Invest in 6,000+ U.S. stocks and ETFs
Own a slice of SLDB from only US$10 with fractional shares